Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.60 is 39% above its 5-year average of -2.61, near the high end of its 5-year range (-3.93–-0.75).
37.62% above its 12-month average of -2.56.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.57.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:42:45.747Z. Historical observations retain their original dates. Historical series through 2020-08-06.
EARNINGS PER SHARE (EPS)
-1.60
EARNINGS PER SHARE (EPS) AVG TTM
-2.56
EARNINGS PER SHARE (EPS) AVG 3Y
-2.45
EARNINGS PER SHARE (EPS) AVG 5Y
-2.61
EARNINGS PER SHARE (EPS) AVG 10Y
-3.14
EARNINGS PER SHARE (EPS) AVG 15Y
-2.99
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+37.62%
CURRENT VS 3Y AVG
+34.76%
CURRENT VS 5Y AVG
+38.74%
CURRENT VS 10Y AVG
+49.00%
CURRENT VS 15Y AVG
+46.43%
CURRENT VS 20Y AVG
N/A
MediWound Ltd.
Market Cap
$171.77M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.56
3Y Avg
-2.45
5Y Avg
-2.61
Market Cap
$172.60M
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.39
3Y Avg
-0.36
5Y Avg
-0.55
Market Cap
$170.72M
Earnings Per Share (EPS)
-27.00
TTM Avg
-15.00
3Y Avg
-27.00
5Y Avg
-32.85
Market Cap
$169.48M
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.50
3Y Avg
-2.00
5Y Avg
-2.13
Market Cap
$170.03M
Earnings Per Share (EPS)
-2.80
TTM Avg
-1.25
3Y Avg
-14.14
5Y Avg
-22.50
Market Cap
$178.54M
Earnings Per Share (EPS)
-1.57
TTM Avg
-5.27
3Y Avg
-99.59
5Y Avg
-93.21
Market Cap
$180.32M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.59
3Y Avg
-0.77
5Y Avg
-0.88
Market Cap
$163.00M
Earnings Per Share (EPS)
-1.02
TTM Avg
-0.60
3Y Avg
-1.87
5Y Avg
-1.57
Market Cap
$157.47M
Earnings Per Share (EPS)
-0.90
TTM Avg
-1.19
3Y Avg
-2.61
5Y Avg
-1.83
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $171.77M | -1.60 | -2.56 | -2.45 | -2.61 |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.60M | -0.41 | -0.39 | -0.36 | -0.55 |
| Cue Biopharma, Inc. (CUE)vs › | $170.72M | -27.00 | -15.00 | -27.00 | -32.85 |
| Nkarta, Inc. (NKTX)vs › | $169.48M | -1.57 | -1.50 | -2.00 | -2.13 |
| Precision BioSciences, Inc. (DTIL)vs › | $170.03M | -2.80 | -1.25 | -14.14 | -22.50 |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.54M | -1.57 | -5.27 | -99.59 | -93.21 |
| Journey Medical Corporation (DERM)vs › | $180.32M | -0.23 | -0.59 | -0.77 | -0.88 |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | -1.02 | -0.60 | -1.87 | -1.57 |
| Inogen, Inc. (INGN)vs › | $157.47M | -0.90 | -1.19 | -2.61 | -1.83 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | -0.05 | -0.06 | -0.06 |
Trailing EPS (TTM)
$-1.60
Forward EPS (Est.)
$-2.19
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.10 |
| 2024-12-31 | -3.03 |
| 2023-12-31 | -0.75 |
| 2022-12-31 | -3.93 |
| 2021-12-31 | -3.48 |
| 2020-12-31 | -2.38 |
| 2019-12-31 | 1.26 |
| 2018-12-31 | -0.28 |
| 2017-12-31 | -6.64 |
| 2016-12-31 | -6.05 |
| 2015-12-31 | -7.13 |
| 2014-12-31 | -6.65 |
| 2013-12-31 | -5.28 |
| 2012-12-31 | 3.76 |
| 2011-12-31 | -2.12 |
